Copyright
©The Author(s) 2025.
World J Hepatol. Feb 27, 2025; 17(2): 101741
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.101741
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.101741
Table 2 Analysis of clinical symptoms at onset in the two groups
| DILI (n = 89) | DILI + NAFL (n = 110) | P value | |
| Urine color deepens | 51 (57.3) | 61 (55.45) | 0.794 |
| Fatigue | 43 (48.31) | 48 (43.64) | 0.51 |
| Poor appetite | 47 (52.81) | 42 (38.18) | 0.039 |
| Nausea | 14 (15.73) | 6 (5.45) | 0.017 |
| Bloating | 6 (6.74) | 11 (10) | 0.414 |
| Abdominal pain | 7 (7.87) | 6 (5.45) | 0.494 |
| Fever | 4 (4.49) | 5 (4.55) | 0.986 |
| Pruritic | 1 (1.12) | 1 (0.91) | 1 |
- Citation: Zhao Y, Li JZ, Liu YG, Zhu YJ, Zhang Y, Zheng WW, Ma L, Li J, Wang CY. Clinical features and prognosis of drug-induced liver injury in patients with non-alcoholic fatty liver. World J Hepatol 2025; 17(2): 101741
- URL: https://www.wjgnet.com/1948-5182/full/v17/i2/101741.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i2.101741